VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SBFM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SBFMSunshine Biopharma, Inc.
$2.08$1M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSBFMQuarterly Financials

Sunshine Biopharma, Inc. (SBFM) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Sunshine Biopharma, Inc. (SBFM) quarterly income statement — complete revenue, gross profit & net income history

SBFM Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue8.09M8.58M9.42M9.41M8.9M9.59M8.44M9.3M7.54M7.68M5.96M5.56M4.89M3.94M132.81K150.31K122.64K85.12K50.38K52.87K
Revenue Growth %-9.13%-10.6%11.64%1.15%18.04%24.93%41.59%67.3%54.09%94.94%4385.93%3599.67%3890.42%4528.68%163.63%184.27%206.17%203.85%193.74%249.12%
Cost of Goods Sold5.98M5.65M6.34M5.99M6.17M6.5M5.57M6.95M5.19M5.11M3.97M3.61M3.07M2.45M65.78K74.68K59.84K61.29K19.51K18.52K
COGS % of Revenue73.99%65.84%67.36%63.63%69.33%67.76%66.02%74.67%68.78%66.56%66.59%64.88%62.65%62.15%49.53%49.69%48.8%72%38.72%35.02%
Gross Profit2.1M2.93M3.07M3.42M2.73M3.09M2.87M2.36M2.35M2.57M1.99M1.95M1.83M1.49M67.03K75.62K62.8K23.83K30.87K34.36K
Gross Margin %26.01%34.16%32.64%36.37%30.67%32.24%33.98%25.33%31.22%33.44%33.41%35.12%37.35%37.85%50.47%50.31%51.2%28%61.28%64.98%
Gross Profit Growth %-22.94%-5.27%7.24%45.27%15.97%20.44%44.01%20.66%28.78%72.22%2869.42%2482.18%2811.02%6157.61%117.12%120.1%191.58%35.78%185.57%244.14%
Operating Expenses3.5M4.59M3.61M4.42M4.03M5.13M3.97M3.62M3.7M3.76M2.77M2.97M3.66M24.85M1.79M771.42K1.29M303.46K527.13K422.96K
OpEx % of Revenue43.27%53.49%38.29%46.92%45.23%53.47%47.09%38.96%49.13%48.9%46.49%53.35%74.73%630.86%1344.05%513.23%1048.69%356.52%1046.39%799.93%
Selling, General & Admin3.34M8.69M3.27M4.03M3.64M4.81M3.73M2.99M3.36M2.82M2.44M2.47M3.13M6.41M1.42M723.19K921.4K209.08K301.48K228K
SG&A % of Revenue41.27%101.26%34.73%42.87%40.85%50.1%44.16%32.16%44.61%36.72%40.99%44.36%63.87%162.75%1070.5%481.14%751.28%245.63%598.46%431.22%
Research & Development31.72K-530.81K119.3K196.23K215.28K149.27K126.36K436.24K222.03K816.33K238.01K368.56K432.93K41.76K362.5K45.94K361.65K91.2K222.47K191.76K
R&D % of Revenue0.39%-6.19%1.27%2.09%2.42%1.56%1.5%4.69%2.94%10.63%4%6.63%8.85%1.06%272.95%30.57%294.88%107.14%441.61%362.67%
Other Operating Expenses129.66K-1000K215.73K185.21K174.97K174.24K121.1K196.67K118.52K119.13K89.8K131.53K98.43K1000K7892.29K3.11K3.18K3.18K3.19K
Operating Income-1.4M-1.66M-531.96K-992.85K-1.3M-2.04M-1.11M-1.27M-1.35M-1.19M-779.47K-1.01M-1.83M-23.36M-1.72M-695.8K-1.22M-279.63K-496.26K-388.6K
Operating Margin %-17.25%-19.33%-5.65%-10.55%-14.56%-21.24%-13.12%-13.63%-17.91%-15.46%-13.08%-18.23%-37.37%-593.01%-1293.58%-462.92%-997.48%-328.52%-985.11%-734.95%
Operating Income Growth %-7.71%18.62%51.92%21.72%4.06%-71.64%-41.94%-25.09%26.16%94.92%54.63%-45.72%-49.5%-8255.16%-246.19%-79.05%4.1%18.55%-637.51%-202.25%
EBITDA-1.32M-1.56M-435.8K-920.31K-1.23M-1.97M-1.04M-1.22M-1.31M-1.14M-742.27K-979K-1.79M-23.34M-1.72M-693.51K-1.22M-276.45K-493.08K-385.41K
EBITDA Margin %-16.3%-18.18%-4.63%-9.78%-13.83%-20.56%-12.35%-13.09%-17.34%-14.91%-12.46%-17.61%-36.66%-592.53%-1292.99%-461.39%-994.95%-324.78%-978.79%-728.91%
EBITDA Growth %-7.13%20.92%58.17%24.4%5.89%-72.27%-40.34%-24.35%27.1%95.1%56.77%-41.17%-47.04%-8344.52%-248.26%-79.94%4.1%18.63%-673.03%-207.35%
D&A (Non-Cash Add-back)76.86K98.58K96.16K72.53K64.79K65.41K64.63K50.88K42.62K42.35K37.2K34.88K34.71K18.98K7892.29K3.11K3.18K3.18K3.19K
EBIT-1.24M-1.73M-1.02M-1.98M-1.22M-2.28M-982.59K-837.75K-1.21M-999.65K-572K-811.1K-1.62M-23.25M-1.46M-538.87K-1.22M703.75K-3.99M-2.68M
Net Interest Income48.43K57.47K75.35K72.72K75.37K90.78K108.61K143.75K94.91K157.5K168.9K199.72K172.81K85.12K260.94K146.04K-12.86K-36.63K-46.85K-195.63K
Interest Income48.43K57.47K75.35K72.72K75.37K99.31K108.61K144K144.09K187.61K207.43K203.05K213.88K111.67K260.94K146.04K3002
Interest Expense000008.53K024549.18K30.11K38.53K3.33K41.08K26.55K0012.86K36.63K46.85K195.63K
Other Income/Expense151.73K-74.33K-489.3K-987.15K75.82K-249.23K123.77K430.29K89.14K157.46K168.94K199.46K172.82K84.6K260.96K156.92K-12.87K946.75K-3.54M-2.49M
Pretax Income-1.24M-1.73M-1.02M-1.98M-1.22M-2.29M-982.59K-837.99K-1.26M-1.03M-610.53K-814.43K-1.66M-23.28M-1.46M-538.87K-1.24M667.12K-4.04M-2.88M
Pretax Margin %-15.38%-20.2%-10.84%-21.04%-13.71%-23.83%-11.65%-9.01%-16.73%-13.41%-10.25%-14.65%-33.84%-590.86%-1097.09%-358.51%-1007.98%783.75%-8018.47%-5445.12%
Income Tax0408.37K-137.44K-209.17K-40.16K-128.74K215.22K-343.69K22.35K220.27K40.95K87.68K46.27K233.3K000000
Effective Tax Rate %0%-23.57%13.46%10.56%3.29%5.63%-21.9%41.01%-1.77%-21.39%-6.71%-10.77%-2.79%-1%0%0%0%0%0%0%
Net Income-1.24M-2.14M-883.82K-1.77M-1.18M-2.16M-1.2M-494.3K-1.28M-1.25M-651.48K-902.11K-1.7M-23.51M-1.46M-538.87K-1.24M667.12K-4.04M-2.88M
Net Margin %-15.38%-24.96%-9.39%-18.82%-13.25%-22.49%-14.2%-5.31%-17.02%-16.28%-10.94%-16.22%-34.79%-596.78%-1097.09%-358.51%-1007.98%783.75%-8018.47%-5445.12%
Net Income Growth %-5.43%0.81%26.21%-258.25%8.1%-72.65%-83.86%45.21%24.59%94.68%55.29%-67.41%-37.71%-3624.47%63.93%81.28%80.01%161.55%-478.22%-217.27%
Net Income (Continuing)-1.24M-2.14M-883.82K-1.77M-1.18M-2.16M-1.2M-494.3K-1.28M-1.25M-651.48K-902.11K-1.7M-23.51M-1.46M-538.87K-1.24M667.12K-4.04M-2.88M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-2.50-4.60-1.90-78.00-4.40-8.40-9.40-99.40-400.40-1046.90-507.20-7.10-1545.10-10.40-1600.00-600.00-4689.806.50-31800.00-24200.00
EPS Growth %43.18%45.24%79.79%21.53%98.9%99.2%98.15%-1300%74.09%-9966.35%68.3%98.82%67.05%-260%94.97%97.52%91.68%110.11%-246.41%-79.74%
EPS (Basic)-2.50-4.60-1.90-78.00-4.40-8.40-9.40-99.40-400.40-1046.90-507.20-7.10-1546.10-10.50-1600.00-600.00-4600.006.50-31800.00-24200.00
Diluted Shares Outstanding490.6K415.71K465.17K22.48K270.3K258K126.8K4.97K3.21K1.19K1.28K126.8K1.1K2.26M18.89K792527.29K358.5K254.3K239.3K
Basic Shares Outstanding490.6K415.71K465.17K22.48K270.3K258K126.8K4.97K3.21K1.19K1.28K126.8K1.1K2.24M18.89K792527.29K358.5K254.3K239.3K
Dividend Payout Ratio--------------------